BASILEA PHARMACEUTICA AG ALLSCHWILBASILEA PHARMACEUTICA AG ALLSCHWILBASILEA PHARMACEUTICA AG ALLSCHWIL

BASILEA PHARMACEUTICA AG ALLSCHWIL

No trades
See on Supercharts

Price target

76.900.00 0.00%
The 4 analysts offering 1 year price forecasts for BPMUF have a max estimate of — and a min estimate of —.

Analyst rating

Based on 5 analysts giving stock ratings to BPMUF in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

BPMUF EPS for the last quarter is −2.03 USD despite the estimation of −2.38 USD. In the next quarter EPS is expected to reach 1.04 USD. Track more of BASILEA PHARMACEUTICA AG ALLSCHWIL financials and stay on top of what is up with the company.
In the next quarter BASILEA PHARMACEUTICA AG ALLSCHWIL revenue is expected to reach ‪94.38 M‬ USD. Check out BASILEA PHARMACEUTICA AG ALLSCHWIL revenue and earnings and make informed decisions.
According to analysts, BPMUF price target is 76.90 USD with a max estimate of 104.01 USD and a min estimate of 57.54 USD. Check if this forecast comes true in a year, meanwhile watch BASILEA PHARMACEUTICA AG ALLSCHWIL stock price chart and keep track of the current situation with BPMUF news and stock market news.
We've gathered opinions of 5 analysts rating BPMUF stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.